| |
| |
|
| Insider
Information: |
Mckeon Brian P |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
64,967 |
|
|
Indirect Shares
|
28,050 |
|
|
| Direct
Value |
$17,075,222 |
|
|
|
Indirect Value
|
$9,342,200 |
|
|
| Total
Shares |
93,017 |
|
|
| Total
Value |
$26,417,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
9
|
|
Stock
price went up :
|
1
|
4
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 8.6%
|
 -1.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idexx Laboratories Inc |
IDXX |
EVP, CFO and Treasurer |
2024-02-15 |
30,835 |
2024-02-15 |
18,050 |
Premium* |
|
|
Timberland Co |
TBL |
EVP - F & A; CFO |
2007-03-30 |
0 |
2003-06-30 |
0 |
Premium* |
|
|
Iron Mountain Inc |
IRM |
Chief Financial Officer |
2013-06-07 |
10,991 |
2011-03-11 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2024-02-10 |
23,141 |
2024-02-10 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2020-11-04 |
4 |
OE |
$79.54 |
$2,880,621 |
D/D |
36,216 |
60,916 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2020-11-04 |
4 |
S |
$467.01 |
$17,073,801 |
D/D |
(36,216) |
24,700 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2020-11-06 |
4 |
S |
$472.88 |
$4,762,456 |
I/I |
(10,000) |
18,050 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,642 |
27,356 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-02-14 |
4 |
D |
$544.08 |
$726,347 |
D/D |
(1,335) |
26,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-02-16 |
4 |
S |
$539.58 |
$705,231 |
D/D |
(1,307) |
24,714 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-02-18 |
4 |
OE |
$67.85 |
$100,011 |
D/D |
1,474 |
26,188 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-08-02 |
4 |
B |
$26.43 |
$264,269 |
I/I |
10,000 |
10,000 |
2.1 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
192 |
26,404 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-08-05 |
4 |
D |
$705.76 |
$67,753 |
D/D |
(96) |
26,308 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-08 |
4 |
S |
$625.25 |
$6,283,133 |
D/D |
(10,000) |
26,317 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-08 |
4 |
OE |
$67.85 |
$678,500 |
D/D |
10,000 |
36,317 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-09 |
4 |
OE |
$67.85 |
$428,134 |
D/D |
6,310 |
32,627 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-09 |
4 |
S |
$630.13 |
$3,976,676 |
D/D |
(6,310) |
26,317 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-10 |
4 |
OE |
$67.85 |
$1,357,000 |
D/D |
20,000 |
46,317 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-10 |
4 |
S |
$621.40 |
$12,499,279 |
D/D |
(20,000) |
26,317 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-12 |
4 |
S |
$620.55 |
$5,726,188 |
D/D |
(9,225) |
26,317 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2021-11-12 |
4 |
OE |
$67.85 |
$625,916 |
D/D |
9,225 |
35,542 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,669 |
5,757 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-02-10 |
4 |
D |
$23.55 |
$64,409 |
D/D |
(2,735) |
3,934 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2022-02-14 |
4 |
D |
$505.53 |
$487,331 |
D/D |
(964) |
27,448 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,085 |
28,412 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2022-02-16 |
4 |
OE |
$141.60 |
$99,970 |
D/D |
706 |
28,154 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,585 |
11,519 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
D |
$27.19 |
$21,616 |
D/D |
(795) |
10,724 |
0 |
- |
|
167 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
